The 2012 Leading Paint and Coatings Companies Technological Know-How
US$ 1,480.00
... analyzes: Internally developed and acquired technologies, processes, and related capabilities. Proprietary technologies and patent litigations. The companies analyzed in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. Contains 20 pages
March 2012
20 pages
The 2012 Leading Paint and Coatings Companies Product Portfolio Analyses
US$ 1,480.00
The report presents extensive review of the major paints and coatings companies product lines. The companies analyzed in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. Contains 50 pages
March 2012
50 pages
The 2012 Leading Paint and Coatings Companies Marketing Tactics
US$ 1,480.00
For each company, the report presents: Promotional tactics. Distribution approaches. Product service and support. Customer relations. The companies analyzed in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. Contains 60 pages
March 2012
60 pages
The 2012 Leading Paint and Coatings Companies Comparative Analysis
US$ 680.00
... The companies analyzed in the report: Akzo Nobel, BASF, DuPont, ICI, Kansai Paint, Nippon Paint, PPG, Sherwin-Williams, SigmaKalon, and Valspar. List of Tables Table 1: Leading Paints & Coatings Companies Total Sales and Rank Table 2: Leading Paints & Coatings Companies Sales by Geographic Region ...
March 2012
-
The 2012 French Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... and immunodiagnostics markets, including: Major issues pertaining to the French clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
March 2012
542 pages
The 2012 German Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... and immunodiagnostics markets, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
March 2012
578 pages
The 2012 Italian Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... and immunodiagnostics markets, including: Major issues pertaining to the Italian clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
March 2012
561 pages
The 2012 Japanese Clinical Chemistry and Immunodiagnostics Markets
US$ 5,440.00
... and immunodiagnostics markets, including: Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
March 2012
559 pages
The 2012 Spanish Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... and immunodiagnostics markets, including: Major issues pertaining to the Spanish clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
March 2012
568 pages
The 2012 Clinical Chemistry Market: US, Europe, Japan
US$ 10,000.00
... will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This ... devices, controls, calibrators and others. The Clinical Chemistry Market: US, Europe, Japan" is a unique worldwide market and technology assessment designed to help ...
March 2012
520 pages
The 2012 UK Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... chemistry and immunodiagnostics markets, including: Major issues pertaining to the UK clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, ... market impact during the next ten years. Five- and ten-year volume and sales forecasts for over 100 clinical ...
March 2012
563 pages
The 2012 US Clinical Chemistry and Immunodiagnostics Markets
US$ 8,560.00
... chemistry and immunodiagnostics markets, including: Major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, ... market impact during the next ten years. Five- and ten-year volume and sales forecasts for over 100 clinical ...
March 2012
600 pages
Hemostasis Diagnostics Market Leading Suppliers and Emerging Market Entrants
US$ 2,000.00
This report presents analyses of major current and emerging suppliers of hemostasis products, including: The 2010 sales estimates Market shares Product portfolios Marketing tactics Technological know-how New products in R&D Collaborative arrangements Business strategies. Contains 45 pages
February 2012
45 pages
Emerging Special Hematology Tests and Flow Cytometry Applications
US$ 1,480.00
The report presents an overview of the clinical significance and market needs for major hematology and flow cytometry procedures, including listings of companies developing or marketing new technologies and products. Contains 85 pages
February 2012
85 pages
Emerging Opportunities in Cancer Nucleic Acid Testing
US$ 1,160.00
The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing NAT technologies and products for cancer testing. Contains 45 pages
February 2012
45 pages
Future Infectious Disease Nucleic Acid Testing
US$ 2,000.00
This 360-page report presents an overview of the clinical significance and market needs for major infectious diseases, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products. Contains 360 pages and 20 tables
February 2012
360 pages
Tumor Marker Diagnostic Technologies and Their Potential Market Applications
US$ 1,480.00
... potential applications of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry and biosensors or tumor marker diagnostic testing. Review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. Contains 110 pages
February 2012
110 pages
Future French Tumor Marker Testing Market Outlook
US$ 4,320.00
... Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key ... volume and sales forecasts for over 40 tumor markers performed in French hospitals and commercial laboratories. Placements and installed base of automated ...
February 2012
585 pages
Future German Tumor Marker Testing Market Outlook
US$ 4,320.00
... Comprehensive 585-page analysis of the German tumor marker testing market. Major issues pertaining to the German laboratory practice, as well as key ... volume and sales forecasts over for 40 tumor marker performed in German hospitals, commercial laboratories and physician offices. Placements and installed ...
February 2012
585 pages
Future Italian Tumor Marker Testing Market Outlook
US$ 4,320.00
... Comprehensive 570-page analysis of the Italian tumor marker testing market. Major issues pertaining to the Italian laboratory practice, as well as key ... volume and sales forecasts for over 40 tumor marker performed in Italian hospitals and commercial laboratories. Placements and installed base of automated ...
February 2012
570 pages
Future Japanese Tumor Marker Testing Market Outlook
US$ 5,360.00
Highlights Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well as key ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for ...
February 2012
590 pages
Future Spanish Tumor Marker Testing Market Outlook
US$ 4,320.00
Highlights Comprehensive 565-page analysis of the Spanish tumor marker testing market. Major issues pertaining to the Spanish laboratory practice, as well as key ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 ...
February 2012
565 pages
Future UK Tumor Marker Testing Market Outlook
US$ 4,320.00
... leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for ... base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
February 2012
575 pages
Future US Tumor Marker Testing Market Outlook
US$ 6,960.00
... leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for ... base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
February 2012
620 pages
Future Japanese Nucleic Acid Testing Market Outlook
US$ 6,000.00
Highlights Comprehensive 850-page market segmentation analysis of the Japanese NAT market. Major issues pertaining to the Japanese NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An ...
February 2012
850 pages
Future Spanish Nucleic Acid Testing Market Outlook
US$ 4,720.00
Highlights Comprehensive 850-page market segmentation analysis of the Spanish NAT market. Major issues pertaining to the Spanish NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An ...
February 2012
850 pages
Future UK Nucleic Acid Testing Market Outlook
US$ 4,720.00
... comparison of automated and semiautomated analyzers. Sales and market shares of leading suppliers. Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
February 2012
855 pages
Future US Nucleic Acid Testing Market Outlook
US$ 6,720.00
... comparison of automated and semiautomated analyzers. Sales and market shares of leading suppliers. Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
February 2012
880 pages
Emerging Tumor Markers and Companies Developing Innovative Technologies and Products
US$ 2,280.00
... Factors Lymphokines Immunohistochemical Stains. Overview of the clinical significance and market needs for both current and emerging tumor markers. Extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications. Contains 260 pages ...
February 2012
260 pages
Leading Nucleic Acid Testing Market Players
US$ 2,000.00
This 120-page report presents insightful analyses of current and emerging suppliers of NAT products, including: The 2010 Sales Product portfolio Marketing tactics Technological know-how New products in R&D Collaborative arrangements Business strategies Contains 120 pages
February 2012
120 pages
Future French Nucleic Acid Testing Market Outlook
US$ 4,720.00
Highlights Comprehensive 850-page market segmentation analysis of the French NAT market. Major issues pertaining to the French NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An extensive ...
February 2012
850 pages
Future German Nucleic Acid Testing Market Outlook
US$ 4,720.00
Highlights Comprehensive 850-page market segmentation analysis of the German NAT market. Major issues pertaining to the German NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An extensive ...
February 2012
850 pages
Furure Italian Nucleic Acid Testing Market Outlook
US$ 4,720.00
Highlights Comprehensive 850-page market segmentation analysis of the Italian NAT market. Major issues pertaining to the Italian NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An ...
February 2012
850 pages
Future French Microbiology Testing Market Outlook
US$ 4,720.00
Highlights Comprehensive 980-page analysis of the French microbiology testing market. Major issues pertaining to the French microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current ...
February 2012
980 pages
